Sanofi-aventis and Nichi-Iko to Establish New Joint Venture for Generics in Japan
01-Jun-2010 -
Sanofi-aventis and Nichi-Iko Pharmaceutical Co., Ltd. announced that they have signed an agreement to establish a new joint venture, called sanofi-aventis Nichi-Iko K.K., in order to develop a generic business in Japan.
The new joint venture will be held at 51% by sanofi-aventis K.K. and at 49% ...
generics
Japan
joint ventures
+1